_id
69147934ccc777a4e85d8f2a
Ticker
MIRM
Name
Mirum Pharmaceuticals Inc
Exchange
NASDAQ
Address
950 Tower Lane, Foster City, CA, United States, 94404
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.mirumpharma.com
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. Its lead product candidate is LIVMARLI (maralixibat), an orally administered and minimally absorbed ileal bile acid transporter (IBAT) inhibitor that is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the United States and internationally. The company is also involved in the commercialization of Cholbam, a cholic acid capsule, which is approved as treatment for pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects and for adjunctive treatment of patients with peroxisomal disorders, including peroxisome biogenesis disorder-Zellweger spectrum disorder and Smith-Lemli-Opitz syndrome; and Chenodal, a tablet, which is approved for the treatment of radiolucent stones in the gallbladder, and under Phase 3 development for the treatment cerebrotendinous xanthomatosis. In addition, it develops Volixibat, an oral and minimally absorbed agent designed to inhibit IBAT, currently under Phase 2b clinical trial for the treatment of adult patients with cholestatic liver diseases. The company was incorporated in 2018 and is headquartered in Foster City, California.
Last Close
65.72
Volume
930194
Current Price
65
Change
-1.0955569080949465
Last Updated
2025-12-02T11:51:59.234Z
Image
data:image/webp;base64,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
Ipo Date
2019-07-18T00:00:00.000Z
Market Cap
3598064384
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.834438888888889
Sentiment Sources
18
Rating
4.6
Target Price
87.994
Strong Buy
6
Buy
4
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
133009999
Cost Of Revenue
25537000
Gross Profit
107473000
Operating Expenses
104869999
Operating Income
2603000
Interest Expense
355000
Pretax Income
2643000
Net Income
2905000
Eps
0.05097041976869045
Dividends Per Share
-
Shares Outstanding
51393574
Income Tax Expense
-262000
EBITDA
9060000
Operating Margin
1.9569957293210716
Total Other Income Expense Net
40000
Cash
282021000
Short Term Investments
93527000
Receivables
107132000
Inventories
24021000
Total Current Assets
530575000
Property Plant Equipment
9777000
Total Assets
785115000
Payables
12167000
Short Term Debt
2035000
Long Term Debt
309368000
Total Liabilities
493069000
Equity
292046000
Depreciation
6062000
Change In Working Capital
12145000
Cash From Operations
39681000
Capital Expenditures
187000
Cash From Investing
-2227000
Cash From Financing
16096000
Net Change In Cash
53899000
PE
-
PB
12.684986834265835
ROE
0.9947063133889867
ROA
0.37000948905574343
FCF
39494000
Fcf Percent
0.2969250454621836
Piotroski FScore
4
Health Score
53
Deep Value Investing Score
6
Defensive Investing Score
5.5
Dividend Investing Score
3
Economic Moat Investing Score
4.8
Garp Investing Score
3
Growth Investing Score
2.5
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
5.5
Value Investing Score
5.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
133009999
Quarters > 0 > income Statement > cost Of Revenue
25537000
Quarters > 0 > income Statement > gross Profit
107473000
Quarters > 0 > income Statement > operating Expenses
104869999
Quarters > 0 > income Statement > operating Income
2603000
Quarters > 0 > income Statement > interest Expense
355000
Quarters > 0 > income Statement > pretax Income
2643000
Quarters > 0 > income Statement > net Income
2905000
Quarters > 0 > income Statement > eps
0.05097041976869045
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
56993841
Quarters > 0 > income Statement > income Tax Expense
-262000
Quarters > 0 > income Statement > EBITDA
9060000
Quarters > 0 > income Statement > operating Margin
1.9569957293210716
Quarters > 0 > income Statement > total Other Income Expense Net
40000
Quarters > 0 > balance Sheet > cash
282021000
Quarters > 0 > balance Sheet > short Term Investments
93527000
Quarters > 0 > balance Sheet > receivables
107132000
Quarters > 0 > balance Sheet > inventories
24021000
Quarters > 0 > balance Sheet > total Current Assets
530575000
Quarters > 0 > balance Sheet > property Plant Equipment
9777000
Quarters > 0 > balance Sheet > total Assets
785115000
Quarters > 0 > balance Sheet > payables
12167000
Quarters > 0 > balance Sheet > short Term Debt
2035000
Quarters > 0 > balance Sheet > long Term Debt
309368000
Quarters > 0 > balance Sheet > total Liabilities
493069000
Quarters > 0 > balance Sheet > equity
292046000
Quarters > 0 > cash Flow > net Income
2905000
Quarters > 0 > cash Flow > depreciation
6062000
Quarters > 0 > cash Flow > change In Working Capital
12145000
Quarters > 0 > cash Flow > cash From Operations
39681000
Quarters > 0 > cash Flow > capital Expenditures
187000
Quarters > 0 > cash Flow > cash From Investing
-2227000
Quarters > 0 > cash Flow > cash From Financing
16096000
Quarters > 0 > cash Flow > net Change In Cash
53899000
Quarters > 0 > ratios > PE
0.05097041976869045
Quarters > 0 > ratios > PB
12.684986834265835
Quarters > 0 > ratios > ROE
0.9947063133889867
Quarters > 0 > ratios > ROA
0.37000948905574343
Quarters > 0 > ratios > FCF
39494000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.2969250454621836
Quarters > 0 > health Score
53
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
127785000
Quarters > 1 > income Statement > cost Of Revenue
23421000
Quarters > 1 > income Statement > gross Profit
104364000
Quarters > 1 > income Statement > operating Expenses
109353000
Quarters > 1 > income Statement > operating Income
-4989000
Quarters > 1 > income Statement > interest Expense
3589000
Quarters > 1 > income Statement > pretax Income
-5459000
Quarters > 1 > income Statement > net Income
-5861000
Quarters > 1 > income Statement > eps
-0.11786395442958421
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
49726823
Quarters > 1 > income Statement > income Tax Expense
402000
Quarters > 1 > income Statement > EBITDA
4186000
Quarters > 1 > income Statement > operating Margin
-3.9042141096372815
Quarters > 1 > income Statement > total Other Income Expense Net
-470000
Quarters > 1 > balance Sheet > cash
228122000
Quarters > 1 > balance Sheet > short Term Investments
76430000
Quarters > 1 > balance Sheet > receivables
106836000
Quarters > 1 > balance Sheet > inventories
22941000
Quarters > 1 > balance Sheet > total Current Assets
453398000
Quarters > 1 > balance Sheet > property Plant Equipment
10123000
Quarters > 1 > balance Sheet > total Assets
725825000
Quarters > 1 > balance Sheet > payables
17657000
Quarters > 1 > balance Sheet > short Term Debt
2081000
Quarters > 1 > balance Sheet > long Term Debt
308933000
Quarters > 1 > balance Sheet > total Liabilities
470667000
Quarters > 1 > balance Sheet > equity
255158000
Quarters > 1 > cash Flow > net Income
-5861000
Quarters > 1 > cash Flow > depreciation
6056000
Quarters > 1 > cash Flow > change In Working Capital
-6556000
Quarters > 1 > cash Flow > cash From Operations
12040000
Quarters > 1 > cash Flow > capital Expenditures
126000
Quarters > 1 > cash Flow > cash From Investing
-6599000
Quarters > 1 > cash Flow > cash From Financing
8688000
Quarters > 1 > cash Flow > net Change In Cash
16355000
Quarters > 1 > ratios > PE
-0.11786395442958421
Quarters > 1 > ratios > PB
12.667615732212981
Quarters > 1 > ratios > ROE
-2.297008128296977
Quarters > 1 > ratios > ROA
-0.8074949195742775
Quarters > 1 > ratios > FCF
11914000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
0.09323473021090112
Quarters > 1 > health Score
25
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
111585000
Quarters > 2 > income Statement > cost Of Revenue
23018000
Quarters > 2 > income Statement > gross Profit
88567000
Quarters > 2 > income Statement > operating Expenses
103750000
Quarters > 2 > income Statement > operating Income
-15183000
Quarters > 2 > income Statement > interest Expense
3596000
Quarters > 2 > income Statement > pretax Income
-13648000
Quarters > 2 > income Statement > net Income
-14677000
Quarters > 2 > income Statement > eps
-0.300210325181557
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
48889058
Quarters > 2 > income Statement > income Tax Expense
1029000
Quarters > 2 > income Statement > EBITDA
-4000000
Quarters > 2 > income Statement > operating Margin
-13.606667562844468
Quarters > 2 > income Statement > total Other Income Expense Net
1535000
Quarters > 2 > balance Sheet > cash
211822000
Quarters > 2 > balance Sheet > short Term Investments
65852000
Quarters > 2 > balance Sheet > receivables
95852000
Quarters > 2 > balance Sheet > inventories
22418000
Quarters > 2 > balance Sheet > total Current Assets
410818000
Quarters > 2 > balance Sheet > property Plant Equipment
8771000
Quarters > 2 > balance Sheet > total Assets
690245000
Quarters > 2 > balance Sheet > payables
11639000
Quarters > 2 > balance Sheet > short Term Debt
1644000
Quarters > 2 > balance Sheet > long Term Debt
308509000
Quarters > 2 > balance Sheet > total Liabilities
456989000
Quarters > 2 > balance Sheet > equity
233256000
Quarters > 2 > cash Flow > net Income
-14677000
Quarters > 2 > cash Flow > depreciation
6052000
Quarters > 2 > cash Flow > change In Working Capital
-11297000
Quarters > 2 > cash Flow > cash From Operations
-1961000
Quarters > 2 > cash Flow > capital Expenditures
41000
Quarters > 2 > cash Flow > cash From Investing
-16134000
Quarters > 2 > cash Flow > cash From Financing
6359000
Quarters > 2 > cash Flow > net Change In Cash
-10681000
Quarters > 2 > ratios > PE
-0.300210325181557
Quarters > 2 > ratios > PB
13.623609982165517
Quarters > 2 > ratios > ROE
-6.292228281373255
Quarters > 2 > ratios > ROA
-2.1263464422053038
Quarters > 2 > ratios > FCF
-2002000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.017941479589550568
Quarters > 2 > health Score
17
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
99414000
Quarters > 3 > income Statement > cost Of Revenue
22780000
Quarters > 3 > income Statement > gross Profit
76634000
Quarters > 3 > income Statement > operating Expenses
100856000
Quarters > 3 > income Statement > operating Income
-24222000
Quarters > 3 > income Statement > interest Expense
3579000
Quarters > 3 > income Statement > pretax Income
-24366000
Quarters > 3 > income Statement > net Income
-23790000
Quarters > 3 > income Statement > eps
-0.4921584002812192
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
48338096
Quarters > 3 > income Statement > income Tax Expense
-576000
Quarters > 3 > income Statement > EBITDA
-14731000
Quarters > 3 > income Statement > operating Margin
-24.36477759671676
Quarters > 3 > income Statement > total Other Income Expense Net
-144000
Quarters > 3 > balance Sheet > cash
222503000
Quarters > 3 > balance Sheet > short Term Investments
57812000
Quarters > 3 > balance Sheet > receivables
78286000
Quarters > 3 > balance Sheet > inventories
22403000
Quarters > 3 > balance Sheet > total Current Assets
392788000
Quarters > 3 > balance Sheet > property Plant Equipment
9814000
Quarters > 3 > balance Sheet > total Assets
670754000
Quarters > 3 > balance Sheet > payables
14618000
Quarters > 3 > balance Sheet > short Term Debt
1709000
Quarters > 3 > balance Sheet > long Term Debt
308082000
Quarters > 3 > balance Sheet > total Liabilities
445114000
Quarters > 3 > balance Sheet > equity
225640000
Quarters > 3 > cash Flow > net Income
-23790000
Quarters > 3 > cash Flow > depreciation
6056000
Quarters > 3 > cash Flow > change In Working Capital
-1682000
Quarters > 3 > cash Flow > cash From Operations
-5068000
Quarters > 3 > cash Flow > capital Expenditures
20000
Quarters > 3 > cash Flow > cash From Investing
641000
Quarters > 3 > cash Flow > cash From Financing
5340000
Quarters > 3 > cash Flow > net Change In Cash
-466000
Quarters > 3 > ratios > PE
-0.4921584002812192
Quarters > 3 > ratios > PB
13.92473072150328
Quarters > 3 > ratios > ROE
-10.54334337883354
Quarters > 3 > ratios > ROA
-3.5467548460389353
Quarters > 3 > ratios > FCF
-5088000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.05117991429778502
Quarters > 3 > health Score
17
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
336888000
Annuals > 0 > income Statement > cost Of Revenue
81643000
Annuals > 0 > income Statement > gross Profit
255245000
Annuals > 0 > income Statement > operating Expenses
342851000
Annuals > 0 > income Statement > operating Income
-87606000
Annuals > 0 > income Statement > interest Expense
14311000
Annuals > 0 > income Statement > pretax Income
-86912000
Annuals > 0 > income Statement > net Income
-87942000
Annuals > 0 > income Statement > eps
-1.8505144877217348
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
47523000
Annuals > 0 > income Statement > income Tax Expense
1030000
Annuals > 0 > income Statement > EBITDA
-48972000
Annuals > 0 > income Statement > operating Margin
-26.004488138491133
Annuals > 0 > income Statement > total Other Income Expense Net
694000
Annuals > 0 > balance Sheet > cash
222503000
Annuals > 0 > balance Sheet > short Term Investments
57812000
Annuals > 0 > balance Sheet > receivables
78286000
Annuals > 0 > balance Sheet > inventories
22403000
Annuals > 0 > balance Sheet > total Current Assets
392788000
Annuals > 0 > balance Sheet > property Plant Equipment
9814000
Annuals > 0 > balance Sheet > total Assets
670754000
Annuals > 0 > balance Sheet > payables
14618000
Annuals > 0 > balance Sheet > short Term Debt
1709000
Annuals > 0 > balance Sheet > long Term Debt
308082000
Annuals > 0 > balance Sheet > total Liabilities
445114000
Annuals > 0 > balance Sheet > equity
225640000
Annuals > 0 > cash Flow > net Income
-87942000
Annuals > 0 > cash Flow > depreciation
23629000
Annuals > 0 > cash Flow > change In Working Capital
22591000
Annuals > 0 > cash Flow > cash From Operations
10325000
Annuals > 0 > cash Flow > capital Expenditures
993000
Annuals > 0 > cash Flow > cash From Investing
-90125000
Annuals > 0 > cash Flow > cash From Financing
17699000
Annuals > 0 > cash Flow > net Change In Cash
-63398000
Annuals > 0 > ratios > PE
-1.8505144877217348
Annuals > 0 > ratios > PB
14.74510383797199
Annuals > 0 > ratios > ROE
-38.97447261123914
Annuals > 0 > ratios > ROA
-13.11091696806877
Annuals > 0 > ratios > FCF
9332000
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
0.027700600793141933
Annuals > 0 > health Score
18
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
186374000
Annuals > 1 > income Statement > cost Of Revenue
47039000
Annuals > 1 > income Statement > gross Profit
139335000
Annuals > 1 > income Statement > operating Expenses
248489000
Annuals > 1 > income Statement > operating Income
-109154000
Annuals > 1 > income Statement > interest Expense
15105000
Annuals > 1 > income Statement > pretax Income
-162424000
Annuals > 1 > income Statement > net Income
-163415000
Annuals > 1 > income Statement > eps
-3.9969305217222773
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
40885124
Annuals > 1 > income Statement > income Tax Expense
991000
Annuals > 1 > income Statement > EBITDA
-136490000
Annuals > 1 > income Statement > operating Margin
-58.56718211767736
Annuals > 1 > income Statement > total Other Income Expense Net
-53270000
Annuals > 1 > balance Sheet > cash
286326000
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
67968000
Annuals > 1 > balance Sheet > inventories
22312000
Annuals > 1 > balance Sheet > total Current Assets
387541000
Annuals > 1 > balance Sheet > property Plant Equipment
1990000
Annuals > 1 > balance Sheet > total Assets
646621000
Annuals > 1 > balance Sheet > payables
7416000
Annuals > 1 > balance Sheet > short Term Debt
1104000
Annuals > 1 > balance Sheet > long Term Debt
306421000
Annuals > 1 > balance Sheet > total Liabilities
397951000
Annuals > 1 > balance Sheet > equity
248670000
Annuals > 1 > cash Flow > net Income
-163415000
Annuals > 1 > cash Flow > depreciation
10829000
Annuals > 1 > cash Flow > change In Working Capital
-22640000
Annuals > 1 > cash Flow > cash From Operations
-70944000
Annuals > 1 > cash Flow > capital Expenditures
20109000
Annuals > 1 > cash Flow > cash From Investing
-107200000
Annuals > 1 > cash Flow > cash From Financing
336600000
Annuals > 1 > cash Flow > net Change In Cash
158323000
Annuals > 1 > ratios > PE
-3.9969305217222773
Annuals > 1 > ratios > PB
11.510707086661037
Annuals > 1 > ratios > ROE
-65.71560702939638
Annuals > 1 > ratios > ROA
-25.272145507182724
Annuals > 1 > ratios > FCF
-91053000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-0.4885499050296715
Annuals > 1 > health Score
17
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
77062000
Annuals > 2 > income Statement > cost Of Revenue
12374000
Annuals > 2 > income Statement > gross Profit
64688000
Annuals > 2 > income Statement > operating Expenses
195908000
Annuals > 2 > income Statement > operating Income
-131220000
Annuals > 2 > income Statement > interest Expense
15979000
Annuals > 2 > income Statement > pretax Income
-142071000
Annuals > 2 > income Statement > net Income
-135665000
Annuals > 2 > income Statement > eps
-3.9922026909561934
Annuals > 2 > income Statement > dividends Per Share
5552000
Annuals > 2 > income Statement > shares Outstanding
33982493
Annuals > 2 > income Statement > income Tax Expense
-6406000
Annuals > 2 > income Statement > EBITDA
-122854000
Annuals > 2 > income Statement > operating Margin
-170.27847707041084
Annuals > 2 > income Statement > total Other Income Expense Net
-10851000
Annuals > 2 > balance Sheet > cash
28003000
Annuals > 2 > balance Sheet > short Term Investments
123716000
Annuals > 2 > balance Sheet > receivables
23994000
Annuals > 2 > balance Sheet > inventories
5565000
Annuals > 2 > balance Sheet > total Current Assets
190225000
Annuals > 2 > balance Sheet > property Plant Equipment
2345000
Annuals > 2 > balance Sheet > total Assets
352906000
Annuals > 2 > balance Sheet > payables
8690000
Annuals > 2 > balance Sheet > short Term Debt
931000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
210869000
Annuals > 2 > balance Sheet > equity
142037000
Annuals > 2 > cash Flow > net Income
-135665000
Annuals > 2 > cash Flow > depreciation
3681000
Annuals > 2 > cash Flow > change In Working Capital
-21050000
Annuals > 2 > cash Flow > cash From Operations
-120136000
Annuals > 2 > cash Flow > capital Expenditures
278000
Annuals > 2 > cash Flow > cash From Investing
7700000
Annuals > 2 > cash Flow > cash From Financing
109087000
Annuals > 2 > cash Flow > net Change In Cash
-3337000
Annuals > 2 > ratios > PE
-3.9922026909561934
Annuals > 2 > ratios > PB
16.74996187563804
Annuals > 2 > ratios > ROE
-95.51384498405345
Annuals > 2 > ratios > ROA
-38.44224807739171
Annuals > 2 > ratios > FCF
-120414000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-1.5625600166100024
Annuals > 2 > health Score
16
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
19138000
Annuals > 3 > income Statement > cost Of Revenue
1903000
Annuals > 3 > income Statement > gross Profit
17235000
Annuals > 3 > income Statement > operating Expenses
190648000
Annuals > 3 > income Statement > operating Income
-173413000
Annuals > 3 > income Statement > interest Expense
17590000
Annuals > 3 > income Statement > pretax Income
-83951000
Annuals > 3 > income Statement > net Income
-83988000
Annuals > 3 > income Statement > eps
-2.7698954564651705
Annuals > 3 > income Statement > dividends Per Share
0
Annuals > 3 > income Statement > shares Outstanding
30321722
Annuals > 3 > income Statement > income Tax Expense
37000
Annuals > 3 > income Statement > EBITDA
-65386000
Annuals > 3 > income Statement > operating Margin
-906.1187166893092
Annuals > 3 > income Statement > total Other Income Expense Net
89462000
Annuals > 3 > balance Sheet > cash
31340000
Annuals > 3 > balance Sheet > short Term Investments
125201000
Annuals > 3 > balance Sheet > receivables
3267000
Annuals > 3 > balance Sheet > inventories
1513000
Annuals > 3 > balance Sheet > total Current Assets
166592000
Annuals > 3 > balance Sheet > property Plant Equipment
2550000
Annuals > 3 > balance Sheet > total Assets
294651000
Annuals > 3 > balance Sheet > payables
9166000
Annuals > 3 > balance Sheet > short Term Debt
711000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
174439000
Annuals > 3 > balance Sheet > equity
120212000
Annuals > 3 > cash Flow > net Income
-83988000
Annuals > 3 > cash Flow > depreciation
975000
Annuals > 3 > cash Flow > change In Working Capital
16983000
Annuals > 3 > cash Flow > cash From Operations
-132758000
Annuals > 3 > cash Flow > capital Expenditures
19024000
Annuals > 3 > cash Flow > cash From Investing
48547000
Annuals > 3 > cash Flow > cash From Financing
73466000
Annuals > 3 > cash Flow > net Change In Cash
-10746000
Annuals > 3 > ratios > PE
-2.7698954564651705
Annuals > 3 > ratios > PB
17.65900040944332
Annuals > 3 > ratios > ROE
-69.866569061325
Annuals > 3 > ratios > ROA
-28.504230428540883
Annuals > 3 > ratios > FCF
-151782000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-7.930922771449472
Annuals > 3 > health Score
16
Valuation > metrics > PE
0.05097041976869045
Valuation > metrics > PB
12.684986834265835
Valuation > final Score
40
Valuation > verdict
111.7% Overvalued
Profitability > metrics > ROE
0.9947063133889867
Profitability > metrics > ROA
0.5475192008669839
Profitability > metrics > Net Margin
0.021840463287275118
Profitability > final Score
7
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.6883264965108236
Risk > metrics > Interest Coverage
7.332394366197183
Risk > final Score
59
Risk > verdict
High
Liquidity > metrics > Current Ratio
37.35917476411773
Liquidity > metrics > Quick Ratio
35.66779326855372
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
24
Prev Risks > 1
13
Prev Risks > 2
3
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-13T01:01:58.287Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-11
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.1331
Earnings History > 0 > eps Difference
0.1331
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-04
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.05
Earnings History > 1 > eps Estimate
-0.15
Earnings History > 1 > eps Difference
0.2
Earnings History > 1 > surprise Percent
133.3333
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-06
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.12
Earnings History > 2 > eps Estimate
-0.33
Earnings History > 2 > eps Difference
0.21
Earnings History > 2 > surprise Percent
63.6364
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-06
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.3
Earnings History > 3 > eps Estimate
-0.48
Earnings History > 3 > eps Difference
0.18
Earnings History > 3 > surprise Percent
37.5
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-26
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.49
Earnings History > 4 > eps Estimate
-0.2466
Earnings History > 4 > eps Difference
-0.2434
Earnings History > 4 > surprise Percent
-98.7024
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-04
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.2979
Earnings History > 5 > eps Estimate
-0.45
Earnings History > 5 > eps Difference
0.1521
Earnings History > 5 > surprise Percent
33.8
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-07
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.52
Earnings History > 6 > eps Estimate
-0.47
Earnings History > 6 > eps Difference
-0.05
Earnings History > 6 > surprise Percent
-10.6383
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-08
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.54
Earnings History > 7 > eps Estimate
-0.48
Earnings History > 7 > eps Difference
-0.06
Earnings History > 7 > surprise Percent
-12.5
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-02-28
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.66
Earnings History > 8 > eps Estimate
-0.24
Earnings History > 8 > eps Difference
-0.42
Earnings History > 8 > surprise Percent
-175
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-02
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.57
Earnings History > 9 > eps Estimate
-0.63
Earnings History > 9 > eps Difference
0.06
Earnings History > 9 > surprise Percent
9.5238
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-03
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-1.94
Earnings History > 10 > eps Estimate
-0.8
Earnings History > 10 > eps Difference
-1.14
Earnings History > 10 > surprise Percent
-142.5
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-04
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.8
Earnings History > 11 > eps Estimate
-0.94
Earnings History > 11 > eps Difference
0.14
Earnings History > 11 > surprise Percent
14.8936
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-08
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.99
Earnings History > 12 > eps Estimate
-1.02
Earnings History > 12 > eps Difference
0.03
Earnings History > 12 > surprise Percent
2.9412
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-09
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-1.02
Earnings History > 13 > eps Estimate
-1.07
Earnings History > 13 > eps Difference
0.05
Earnings History > 13 > surprise Percent
4.6729
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-04
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.84
Earnings History > 14 > eps Estimate
-1.15
Earnings History > 14 > eps Difference
0.31
Earnings History > 14 > surprise Percent
26.9565
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-05
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-1.17
Earnings History > 15 > eps Estimate
-1.34
Earnings History > 15 > eps Difference
0.17
Earnings History > 15 > surprise Percent
12.6866
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-09
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-1.66
Earnings History > 16 > eps Estimate
0.35
Earnings History > 16 > eps Difference
-2.01
Earnings History > 16 > surprise Percent
-574.2857
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-15
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-1.55
Earnings History > 17 > eps Estimate
-1.73
Earnings History > 17 > eps Difference
0.18
Earnings History > 17 > surprise Percent
10.4046
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-05
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-1.45
Earnings History > 18 > eps Estimate
-0.65
Earnings History > 18 > eps Difference
-0.8
Earnings History > 18 > surprise Percent
-123.0769
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-06
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-1.69
Earnings History > 19 > eps Estimate
-0.69
Earnings History > 19 > eps Difference
-1
Earnings History > 19 > surprise Percent
-144.9275
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-09
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-1.43
Earnings History > 20 > eps Estimate
-0.72
Earnings History > 20 > eps Difference
-0.71
Earnings History > 20 > surprise Percent
-98.6111
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-11-12
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.86
Earnings History > 21 > eps Estimate
-0.98
Earnings History > 21 > eps Difference
0.12
Earnings History > 21 > surprise Percent
12.2449
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-08-06
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.93
Earnings History > 22 > eps Estimate
-0.87
Earnings History > 22 > eps Difference
-0.06
Earnings History > 22 > surprise Percent
-6.8966
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-05-07
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.86
Earnings History > 23 > eps Estimate
-0.82
Earnings History > 23 > eps Difference
-0.04
Earnings History > 23 > surprise Percent
-4.878
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2020-03-12
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.79
Earnings History > 24 > eps Estimate
-0.85
Earnings History > 24 > eps Difference
0.06
Earnings History > 24 > surprise Percent
7.0588
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-11-06
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.84
Earnings History > 25 > eps Estimate
-0.59
Earnings History > 25 > eps Difference
-0.25
Earnings History > 25 > surprise Percent
-42.3729
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-08-28
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
AfterMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-5.31
Earnings History > 26 > eps Estimate
-0.57
Earnings History > 26 > eps Difference
-4.74
Earnings History > 26 > surprise Percent
-831.5789
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-05-29
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.5953
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
-0.5953
Earnings History > 27 > surprise Percent
-
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. Its lead product candidate is LIVMARLI (maralixibat), an orally administered and minimally absorbed ileal bile acid transporter (IBAT) inhibitor that is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the United States and internationally. The company is also involved in the commercialization of Cholbam, a cholic acid capsule, which is approved as treatment for pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects and for adjunctive treatment of patients with peroxisomal disorders, including peroxisome biogenesis disorder-Zellweger spectrum disorder and Smith-Lemli-Opitz syndrome; and Chenodal, a tablet, which is approved for the treatment of radiolucent stones in the gallbladder, and under Phase 3 development for the treatment cerebrotendinous xanthomatosis. In addition, it develops Volixibat, an oral and minimally absorbed agent designed to inhibit IBAT, currently under Phase 2b clinical trial for the treatment of adult patients with cholestatic liver diseases. The company was incorporated in 2018 and is headquartered in Foster City, California.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ABaird lifts Mirum Pharmaceuticals, Inc. (MIRM) price target on Bluejay Therapeutics acquisition MSN
Read more →Baird Lifts Mirum Pharmaceuticals, Inc. (MIRM) Price Target on Bluejay Therapeutics Acquisition Insider Monkey
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$87.994
Analyst Picks
Strong Buy
6
Buy
4
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 93.33% of the total shares of Mirum Pharmaceuticals Inc
1.
HHG PLC(10.423%)
since
2025/06/30
2.
BlackRock Inc(7.1203%)
since
2025/06/30
3.
Bvf Inc(5.4965%)
since
2025/06/30
4.
Eventide Asset Management, LLC(5.25%)
since
2025/06/30
5.
Vanguard Group Inc(5.1055%)
since
2025/06/30
6.
Novo A/S(2.9859%)
since
2025/06/30
7.
Eventide Gilead N(2.8472%)
since
2025/06/30
8.
T. Rowe Price Associates, Inc.(2.821%)
since
2025/06/30
9.
Citadel Advisors Llc(2.7994%)
since
2025/06/30
10.
State Street Corp(2.7382%)
since
2025/06/30
11.
Vanguard Total Stock Mkt Idx Inv(2.6662%)
since
2025/07/31
12.
TANG CAPITAL MANAGEMENT LLC(2.4604%)
since
2025/06/30
13.
Eventide Healthcare & Life Sciences I(2.3778%)
since
2025/06/30
14.
iShares Russell 2000 ETF(2.0837%)
since
2025/08/31
15.
Geode Capital Management, LLC(2.0495%)
since
2025/06/30
16.
ClearBridge Advisors, LLC(2.0453%)
since
2025/06/30
17.
Polar Capital Holdings PLC(1.9408%)
since
2025/06/30
18.
Polar Capital Biotech S Inc(1.9408%)
since
2025/07/31
19.
Rock Springs Capital Management LP(1.6287%)
since
2025/06/30
20.
Janus Henderson Global Life Sciences D(1.5427%)
since
2025/06/30
21.
Janus Henderson Global Life Sciences(1.5427%)
since
2025/06/30
22.
Lord, Abbett & Co LLC(1.535%)
since
2025/06/30
23.
US Small-Cap Growth II Equity Comp(1.4257%)
since
2025/06/30
24.
ClearBridge Small Cap Growth A(1.4069%)
since
2025/07/31
25.
Pictet Asset Manangement SA(1.3957%)
since
2025/06/30
26.
ClearBridge Small Cap Growth(1.3916%)
since
2025/07/31
27.
Janus Henderson Triton D(1.3518%)
since
2025/06/30
28.
Janus Henderson US SMID Cap Growth(1.3518%)
since
2025/06/30
29.
Janus Henderson US SMID Cap Growth MA(1.3518%)
since
2025/06/30
30.
BOONE CAPITAL MANAGEMENT LLC(1.2768%)
since
2025/06/30
31.
Janus Global Life Science AUSD(1.2765%)
since
2025/06/30
32.
Janus Henderson Glb Life Scn I2 USD(1.2643%)
since
2025/07/31
33.
T. Rowe Price New Horizons(1.249%)
since
2025/07/31
34.
Franklin Resources Inc(1.1816%)
since
2025/06/30
35.
Nuveen, LLC(1.1749%)
since
2025/06/30
36.
Woodline Partners LP(1.1304%)
since
2025/06/30
37.
Janus Henderson Venture D(0.9571%)
since
2025/06/30
38.
Janus Henderson US Small Cap Growth(0.9571%)
since
2025/06/30
39.
SPDR® S&P Biotech ETF(0.9023%)
since
2025/08/31
40.
Vanguard Institutional Extnd Mkt Idx Tr(0.8886%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.1331
Date
2025-09-30
EPS Actual
0.05
EPS Estimate
-0.15
EPS Difference
0.2
Surprise Percent
133.3333%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.